Detail Information of Microbiota Influence

General Information of Drug Transporter (DT)
DT ID DTD0020 Transporter Info
Gene Name SLC10A2
Transporter Name Apical sodium-dependent bile acid transporter
Gene ID
6555
UniProt ID
Q12908
Microbiota Influence of This DT (MBI)

Bacteria: Bacteroidota

   Genus: Bacteroides

     Bacteroides fragilis 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Down regulating of SLC10A2 expression in health condition [1] , [2]

Regulating Factor
Glycoursodeoxycholic acid

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Phenotype

 Health [ICD11: N.A]

Studied Tissue

 Kidney

In Vitro Model

 Human kidney human embryonic kidney 293 cells (HEK 293)

Detailed Description

 The metabolite glycoursodeoxycholic acid generated from the Bacteroides fragilis has been reported to decrease the expression of the drug transporter SLC10A2.

Bacteria: Verrucomicrobiota

   Genus: Akkermansia

     Akkermansia muciniphila 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Up regulating of SLC10A2 expression in metabolic dysfunction-associated fatty liver disease condition [3]

Studied Phenotype

 Metabolic dysfunction-associated fatty liver disease [ICD11: DB95]

Studied Tissue

 Ileum

In Vivo Model

 C57BL/6 mice

Detailed Description

 The Akkermansia muciniphila ATCC BAA-835 has been reported to increase the expression of the drug transporter SLC10A2.

Bacteria: Host unspecified microbiota

   Genus: Unknown microbiota

     Host unspecified microbiota 

Click to Show/Hide the Full List 23 Microbe Influence Related to This Species      

       Microbe Influence 1

 Down regulating of SLC10A2 expression in the health condition [4] , [5]

Regulating Factor
2,3,7,8-tetrachlorodibenzofuran

Studied Tissue

 Ileum

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite 2,3,7,8-tetrachlorodibenzofuran generated from the metabolism of dietary dough pills by the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC10A2.

       Microbe Influence 2

 Down regulating of SLC10A2 expression in the health condition [4] , [6]

Regulating Factor
Chenodeoxycholic acid

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Ileum

In Vivo Model

 Cyp8b1 KO mice

Detailed Description

 The metabolite chenodeoxycholic acid generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC10A2.

       Microbe Influence 3

 Down regulating of SLC10A2 expression in the health condition [4] , [6]

Regulating Factor
Cholic acid

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Ileum

In Vivo Model

 Cyp8b1 KO mice

Detailed Description

 The metabolite cholic acid generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC10A2.

       Microbe Influence 4

 Down regulating of SLC10A2 expression in the health condition [4] , [6]

Regulating Factor
Deoxycholic acid

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Ileum

In Vivo Model

 Cyp8b1 KO mice

Detailed Description

 The metabolite deoxycholic acid generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC10A2.

       Microbe Influence 5

 Down regulating of SLC10A2 expression in the health condition [7] , [8]

Regulating Factor
Bile acid (Chenodeoxycholic acid)

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Ileum

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (chenodeoxycholic acid) generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC10A2.

       Microbe Influence 6

 Down regulating of SLC10A2 expression in the health condition [7] , [8]

Regulating Factor
Bile acid (Chenodeoxycholic acid)

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Colon

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (chenodeoxycholic acid) generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC10A2.

       Microbe Influence 7

 Up regulating of SLC10A2 expression in the health condition [7] , [8]

Regulating Factor
Bile acid (Chenodeoxycholic acid)

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Jejunum

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (chenodeoxycholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLC10A2.

       Microbe Influence 8

 Down regulating of SLC10A2 expression in the health condition [7] , [8]

Regulating Factor
Bile acid (Cholic acid)

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Ileum

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (cholic acid) generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC10A2.

       Microbe Influence 9

 Down regulating of SLC10A2 expression in the health condition [7] , [8]

Regulating Factor
Bile acid (Cholic acid)

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Colon

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (cholic acid) generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC10A2.

       Microbe Influence 10

 Up regulating of SLC10A2 expression in the health condition [7] , [8]

Regulating Factor
Bile acid (Cholic acid)

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Jejunum

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (cholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLC10A2.

       Microbe Influence 11

 Down regulating of SLC10A2 expression in the health condition [7] , [8]

Regulating Factor
Bile acid (Deoxycholic acid)

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Ileum

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (deoxycholic acid) generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC10A2.

       Microbe Influence 12

 Down regulating of SLC10A2 expression in the health condition [7] , [8]

Regulating Factor
Bile acid (Deoxycholic acid)

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Colon

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (deoxycholic acid) generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC10A2.

       Microbe Influence 13

 Up regulating of SLC10A2 expression in the health condition [7] , [8]

Regulating Factor
Bile acid (Deoxycholic acid)

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Jejunum

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (deoxycholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLC10A2.

       Microbe Influence 14

 Down regulating of SLC10A2 expression in the health condition [7] , [8]

Regulating Factor
Bile acid (Hyodeoxycholic acid)

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Ileum

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (hyodeoxycholic acid) generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC10A2.

       Microbe Influence 15

 Down regulating of SLC10A2 expression in the health condition [7] , [8]

Regulating Factor
Bile acid (Hyodeoxycholic acid)

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Colon

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (hyodeoxycholic acid) generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC10A2.

       Microbe Influence 16

 Up regulating of SLC10A2 expression in the health condition [7] , [8]

Regulating Factor
Bile acid (Hyodeoxycholic acid)

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Jejunum

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (hyodeoxycholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLC10A2.

       Microbe Influence 17

 Down regulating of SLC10A2 expression in the health condition [7] , [8]

Regulating Factor
Bile acid (Lithocholic acid)

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Ileum

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (lithocholic acid) generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC10A2.

       Microbe Influence 18

 Down regulating of SLC10A2 expression in the health condition [7] , [8]

Regulating Factor
Bile acid (Lithocholic acid)

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Colon

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (lithocholic acid) generated from the host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC10A2.

       Microbe Influence 19

 Up regulating of SLC10A2 expression in the health condition [7] , [8]

Regulating Factor
Bile acid (Lithocholic acid)

Regulation Mechanism

 via influence on Bile acid receptor (NR1H4) Transcription Factor Info

Studied Tissue

 Jejunum

In Vivo Model

 C57BL/6J mice

Detailed Description

 The metabolite bile acid (lithocholic acid) generated from the host unspecified microbiota has been reported to increase the expression of the drug transporter SLC10A2.

       Microbe Influence 20

 Down regulating of SLC10A2 expression in conventional mice compared with germ-free mice [9]

Regulation Mechanism

 via stimulation of the Transcription factor GATA-4 (GATA4) Transcription Factor Info

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Ileum

In Vivo Model

 C57BL/6 mice

Detailed Description

 The host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC10A2.

       Microbe Influence 21

 Up regulating of SLC10A2 expression in conventional mice compared with germ-free mice [10] , [11]

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Liver

In Vivo Model

 C57BL/6J germ-free mice

Detailed Description

 The host unspecified microbiota has been reported to increase the expression of the drug transporter SLC10A2.

       Microbe Influence 22

 Down regulating of SLC10A2 expression in conventional mice compared with germ-free mice [12]

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Large intestine

In Vivo Model

 C57BL/6 mice

Detailed Description

 The host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC10A2.

       Microbe Influence 23

 Up regulating of SLC10A2 expression in conventional mice compared with germ-free mice [12]

Studied Phenotype

 Conventional mice compared with germ-free mice [ICD11: N.A]

Studied Tissue

 Jejunum

In Vivo Model

 C57BL/6 mice

Detailed Description

 The host unspecified microbiota has been reported to increase the expression of the drug transporter SLC10A2.
References
1 Metabolic control by the microbiome. Genome Med. 2022 Jul 29;14(1):80.
2 Gut microbiota and intestinal FXR mediate the clinical benefits of metformin. Nat Med. 2018 Dec;24(12):1919-1929.
3 Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis. Gut Microbes. 2021 Jan-Dec;13(1):1-19.
4 Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids. Drug Metab Dispos. 2015 Oct;43(10):1505-21.
5 Persistent Organic Pollutants Modify Gut Microbiota-Host Metabolic Homeostasis in Mice Through Aryl Hydrocarbon Receptor Activation. Environ Health Perspect. 2015 Jul;123(7):679-88.
6 Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism. J Intern Med. 2014 Jan;275(1):27-38.
7 Bile Acids Activated Receptors Regulate Innate Immunity. Front Immunol. 2018 Aug 13;9:1853.
8 Importance of Large Intestine in Regulating Bile Acids and Glucagon-Like Peptide-1 in Germ-Free Mice. Drug Metab Dispos. 2015 Oct;43(10):1544-56.
9 Gut microbiota inhibit Asbt-dependent intestinal bile acid reabsorption via Gata4. J Hepatol. 2015 Sep;63(3):697-704.
10 Gut Microbiome and Response to Cardiovascular Drugs. Circ Genom Precis Med. 2019 Sep;12(9):421-429.
11 RNA-Seq Quantification of Hepatic Drug Processing Genes in Germ-Free Mice. Drug Metab Dispos. 2015 Oct;43(10):1572-80.
12 RNA-Seq Profiling of Intestinal Expression of Xenobiotic Processing Genes in Germ-Free Mice. Drug Metab Dispos. 2017 Dec;45(12):1225-1238.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.